Cargando…

Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants

Direct oral anticoagulants (DOAC) have shown an upward prescribing trend in recent years due to favorable pharmacokinetics and pharmacodynamics without requirement for routine coagulation monitoring. However, recent studies have documented inter-individual variability in plasma drug levels of DOACs....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanuri, Sri H., Kreutz, Rolf P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463033/ https://www.ncbi.nlm.nih.gov/pubmed/30658513 http://dx.doi.org/10.3390/jpm9010007

Ejemplares similares

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Pharmacogenomics of anticoagulants: steps toward personal dosage
por: Daly, Ann K
Publicado: (2009)

Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants
por: Gabet, Amélie, et al.
Publicado: (2021)

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015)

Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes
por: Choi, Jihoon, et al.
Publicado: (2018)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China
por: Jin, Tianbo, et al.
Publicado: (2016)

Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population
por: He, Chunjuan, et al.
Publicado: (2021)

Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation
por: Charlton, Alethea, et al.
Publicado: (2021)

Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics
por: Pandi, Maria-Theodora, et al.
Publicado: (2020)

Direct oral anticoagulant: Review article
por: Nasiri, Abdulrahman, et al.
Publicado: (2022)

Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
por: Yoon, Ha-Young, et al.
Publicado: (2022)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Future directions in asthma pharmacogenomics
por: Weiss, Scott T.
Publicado: (2022)

Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province
por: Zhang, Chan, et al.
Publicado: (2018)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients
por: Campos-Staffico, Alessandra M., et al.
Publicado: (2022)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research
por: Kanuri, Sri Harsha, et al.
Publicado: (2023)

Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China
por: Wang, Li, et al.
Publicado: (2015)

Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province
por: Cheng, Yujing, et al.
Publicado: (2020)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

Direct oral anticoagulants: integration into clinical practice
por: Cowell, Richard P W
Publicado: (2014)

Bleeding complications from the direct oral anticoagulants
por: Sholzberg, Michelle, et al.
Publicado: (2015)

Utilization and prescribing patterns of direct oral anticoagulants
por: Whitworth, Maegan M, et al.
Publicado: (2017)

The Reversal of Direct Oral Anticoagulants in Animal Models
por: Honickel, Markus, et al.
Publicado: (2017)

Perioperative management of patients on direct oral anticoagulants
por: Dubois, Virginie, et al.
Publicado: (2017)

Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Global access to affordable direct oral anticoagulants
por: Neumann, Ignacio, et al.
Publicado: (2021)

Inherited Thrombophilia in the Era of Direct Oral Anticoagulants
por: Khider, Lina, et al.
Publicado: (2022)

Reproductive issues in women on direct oral anticoagulants
por: Beyer‐Westendorf, Jan, et al.
Publicado: (2021)

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)

Atraumatic Splenic Rupture on Direct Oral Anticoagulation
por: Jessica, Barnes, et al.
Publicado: (2022)

Serum or Plasma for Quantification of Direct Oral Anticoagulants?
por: Aakerøy, Rachel, et al.
Publicado: (2022)

Liver injury from direct oral anticoagulants
por: Juneja, Deven, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ihcemuobvcnb12i33t6h5u5ju6